Logo image of KAVL

KAIVAL BRANDS INNOVATIONS GR (KAVL) Stock Fundamental Analysis

NASDAQ:KAVL - Nasdaq - US4831044023 - Common Stock - Currency: USD

0.5255  +0 (+0.75%)

After market: 0.5274 +0 (+0.36%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to KAVL. KAVL was compared to 19 industry peers in the Distributors industry. The financial health of KAVL is average, but there are quite some concerns on its profitability. KAVL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KAVL had negative earnings in the past year.
KAVL had a negative operating cash flow in the past year.
In the past 5 years KAVL reported 4 times negative net income.
KAVL had negative operating cash flow in 4 of the past 5 years.
KAVL Yearly Net Income VS EBIT VS OCF VS FCFKAVL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

KAVL's Return On Assets of -75.84% is on the low side compared to the rest of the industry. KAVL is outperformed by 84.21% of its industry peers.
KAVL has a Return On Equity of -87.15%. This is amonst the worse of the industry: KAVL underperforms 84.21% of its industry peers.
Industry RankSector Rank
ROA -75.84%
ROE -87.15%
ROIC N/A
ROA(3y)-72.37%
ROA(5y)-40.78%
ROE(3y)-93.34%
ROE(5y)-49.66%
ROIC(3y)N/A
ROIC(5y)N/A
KAVL Yearly ROA, ROE, ROICKAVL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

KAVL has a better Gross Margin (68.14%) than 100.00% of its industry peers.
KAVL's Gross Margin has improved in the last couple of years.
KAVL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.05%
GM growth 5YN/A
KAVL Yearly Profit, Operating, Gross MarginsKAVL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

KAVL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KAVL has more shares outstanding
Compared to 5 years ago, KAVL has more shares outstanding
Compared to 1 year ago, KAVL has an improved debt to assets ratio.
KAVL Yearly Shares OutstandingKAVL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
KAVL Yearly Total Debt VS Total AssetsKAVL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

KAVL has an Altman-Z score of -4.65. This is a bad value and indicates that KAVL is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of KAVL (-4.65) is worse than 78.95% of its industry peers.
There is no outstanding debt for KAVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -4.65
ROIC/WACCN/A
WACC15.76%
KAVL Yearly LT Debt VS Equity VS FCFKAVL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

KAVL has a Current Ratio of 1.88. This is a normal value and indicates that KAVL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.88, KAVL perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
KAVL has a Quick Ratio of 1.88. This is a normal value and indicates that KAVL is financially healthy and should not expect problems in meeting its short term obligations.
KAVL has a Quick ratio of 1.88. This is in the better half of the industry: KAVL outperforms 78.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
KAVL Yearly Current Assets VS Current LiabilitesKAVL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

KAVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.20%, which is quite impressive.
KAVL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -86.91%.
KAVL shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -51.07% yearly.
EPS 1Y (TTM)58.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.92%
Revenue 1Y (TTM)-86.91%
Revenue growth 3Y-51.07%
Revenue growth 5YN/A
Sales Q2Q%-97.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KAVL Yearly Revenue VS EstimatesKAVL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 20M 40M 60M 80M
KAVL Yearly EPS VS EstimatesKAVL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KAVL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KAVL Price Earnings VS Forward Price EarningsKAVL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KAVL Per share dataKAVL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KAVL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KAIVAL BRANDS INNOVATIONS GR

NASDAQ:KAVL (7/11/2025, 8:00:02 PM)

After market: 0.5274 +0 (+0.36%)

0.5255

+0 (+0.75%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)06-16 2025-06-16
Earnings (Next)09-18 2025-09-18
Inst Owners1.63%
Inst Owner Change0%
Ins Owners20.19%
Ins Owner Change0%
Market Cap6.06M
Analysts82.86
Price TargetN/A
Short Float %0.33%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.57
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 17.17
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.15
BVpS0.92
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.84%
ROE -87.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.14%
FCFM N/A
ROA(3y)-72.37%
ROA(5y)-40.78%
ROE(3y)-93.34%
ROE(5y)-49.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.05%
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z -4.65
F-Score4
WACC15.76%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-86.91%
Revenue growth 3Y-51.07%
Revenue growth 5YN/A
Sales Q2Q%-97.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.5%
OCF growth 3YN/A
OCF growth 5YN/A